KLAS: Regardless of vendor, MU attestation generally successful
Data from the Centers for Medicare & Medicaid Services (CMS) show that both large and small hospital vendors found success in the first year of meaningful use attestation, according to market researcher KLAS.
Despite a longer history of EHR use, larger hospitals using Allscripts, Cerner, Epic, McKesson, MediTech or Siemens Healthcare were not the only providers successfully attesting.
Standalone, community and critical access hospitals represented more than one-third of attestations with CPSI, Healthland, HMS and MediTech.
The Orem, Utah-based researcher interviewed 104 providers that successfully attested for meaningful use to analyze their vendor successes and struggles. “Approximately, one out of seven hospitals in America has attested, and most of those said meaningful use requirements were close to what they were already planning,” the report stated.
Although large vendors like Cerner and Epic met already high expectations, some vendors on the CMS chart were more surprising, the organization found. CPSI was a standout in the community space with 139 hospitals, second only to Epic in having the largest percent of their client base successfully attest. Though not without their challenges, community vendors Healthland and HMS also delivered significant numbers of successful clients.
Some large vendors-like Allscripts, McKesson and Siemens-had successful attesters, but it was a small number compared to the size of their client base. KLAS reported that Meditech is both a success and a struggle for providers. While they have the highest number of successful attesters at 203, the bulk of their attesters came from one large integrated delivery network (IDN). The biggest Meditech “challenges for meaningful use are computerized physician order entry (CPOE), clinical adoption and moving from paper to an electronic culture,” the report stated.
Fifty-four percent of clients deferred medication reconciliation while 73 percent deferred summary of care at transitions. The top three investments needed to meet meaningful use Stage 1, according to the report, are hardware, interfaces and EMR upgrades.
Regardless of vendor, most providers described challenges with adopting CPOE and problems lists, reporting quality measures and interfacing. “CPSI and Siemens were the only platforms whose clients didn’t struggle with reporting,” the report noted.
Depending on the vendor, some providers also saw a higher return-on-investment for their meaningful use expenses than others, with the community hospitals covering their MU costs more easily than larger IDNs. Additionally, providers shared advice based on their experience with MU attestation:
Despite a longer history of EHR use, larger hospitals using Allscripts, Cerner, Epic, McKesson, MediTech or Siemens Healthcare were not the only providers successfully attesting.
Standalone, community and critical access hospitals represented more than one-third of attestations with CPSI, Healthland, HMS and MediTech.
The Orem, Utah-based researcher interviewed 104 providers that successfully attested for meaningful use to analyze their vendor successes and struggles. “Approximately, one out of seven hospitals in America has attested, and most of those said meaningful use requirements were close to what they were already planning,” the report stated.
Although large vendors like Cerner and Epic met already high expectations, some vendors on the CMS chart were more surprising, the organization found. CPSI was a standout in the community space with 139 hospitals, second only to Epic in having the largest percent of their client base successfully attest. Though not without their challenges, community vendors Healthland and HMS also delivered significant numbers of successful clients.
Some large vendors-like Allscripts, McKesson and Siemens-had successful attesters, but it was a small number compared to the size of their client base. KLAS reported that Meditech is both a success and a struggle for providers. While they have the highest number of successful attesters at 203, the bulk of their attesters came from one large integrated delivery network (IDN). The biggest Meditech “challenges for meaningful use are computerized physician order entry (CPOE), clinical adoption and moving from paper to an electronic culture,” the report stated.
Fifty-four percent of clients deferred medication reconciliation while 73 percent deferred summary of care at transitions. The top three investments needed to meet meaningful use Stage 1, according to the report, are hardware, interfaces and EMR upgrades.
Regardless of vendor, most providers described challenges with adopting CPOE and problems lists, reporting quality measures and interfacing. “CPSI and Siemens were the only platforms whose clients didn’t struggle with reporting,” the report noted.
Depending on the vendor, some providers also saw a higher return-on-investment for their meaningful use expenses than others, with the community hospitals covering their MU costs more easily than larger IDNs. Additionally, providers shared advice based on their experience with MU attestation:
- Engage clinical users
- Understand meaningful use requirements
- Track progress
- Begin early